Related references
Note: Only part of the references are listed.British HIV Association guidelines for the management of coinfection with HIV-1 and hepatitis B or C virus 2010
G. Brook et al.
HIV MEDICINE (2010)
Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals
Gail V. Matthews et al.
AIDS (2009)
Hepatitis B and long-term HIV outcomes in coinfected HAART recipients
Christopher J. Hoffmann et al.
AIDS (2009)
Impact of Hepatitis B Virus Infection on the Progression of AIDS and Mortality in HIV-Infected Individuals: A Cohort Study and Meta-Analysis
Georgios K. Nikolopoulos et al.
CLINICAL INFECTIOUS DISEASES (2009)
Long-Term Monitoring Shows Hepatitis B Virus Resistance to Entecavir in Nucleoside-Naive Patients Is Rare Through 5 Years of Therapy
Daniel J. Tenney et al.
HEPATOLOGY (2009)
Long-term outcome of tenofovir disoproxil fumarate use against hepatitis B in an HIV-coinfected cohort
G. Alvarez-Uria et al.
HIV MEDICINE (2009)
Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy
Mario Guimaraes Pessoa et al.
AIDS (2008)
The anti-HIV activity of entecavir: a multicentre evaluation of lamivudine-experienced and lamivudine-naive patients
Joe Sasadeusz et al.
AIDS (2008)
Tenofovir-based rescue therapy for advanced liver disease in 6 patients coinfected with HIV and hepatitis B virus and receiving lamivudine
Sonia Gutierrez et al.
CLINICAL INFECTIOUS DISEASES (2008)
Entecavir therapy induces de novo HIV reverse-transcriptase M184V mutation in an antiretroviral therapy-naive patient
Martin R. Jakobsen et al.
CLINICAL INFECTIOUS DISEASES (2008)
A case of HIV co-infected with hepatitis B virus precore/core deletion mutant treated by entecavir
Koji Fukushima et al.
HEPATOLOGY RESEARCH (2008)
European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults
J. K. Rockstroh et al.
HIV MEDICINE (2008)
Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study
L. H. Omland et al.
HIV MEDICINE (2008)
British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008
B. G. Gazzard
HIV MEDICINE (2008)
Efficacy and safety of entecavir in lamivudine-refractory patients with chronic hepatitis B: Randomized controlled trial in Japanese patients
Fumitaka Suzuki et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Hepatitis B virus DNA levels at week 4 of lamivudine treatment predict the 5-year ideal response
Man-Fung Yuen et al.
HEPATOLOGY (2007)
Low resistance to adefovir combined with lamivudine: A 3-year study of 145 lamivudine-resistant hepatitis B patients
Pie-Fro Lampertico et al.
GASTROENTEROLOGY (2007)
Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection
Guenther Schmutz et al.
AIDS (2006)
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
Joseph F. Perz et al.
JOURNAL OF HEPATOLOGY (2006)
Liver-related deaths in persons infected with the human immunodeficiency virus -: The D:A:D study
Rainer Weber
ARCHIVES OF INTERNAL MEDICINE (2006)
Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study
Gang Chen et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B
Morris Sherman et al.
GASTROENTEROLOGY (2006)
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
TT Chang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort
D Konopnicki et al.
AIDS (2005)
Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy
MF Yuen et al.
HEPATOLOGY (2001)
Share Paper
